Sleep drug may help smokers stay Smoke-Free
NCT ID NCT07328594
First seen Jan 11, 2026 · Last updated May 09, 2026 · Updated 24 times
Summary
This study tests whether daridorexant, a recently FDA-approved insomnia drug, can improve sleep quality and daytime alertness in smokers who are trying to quit. Poor sleep is a major reason people relapse during a quit attempt. The study will enroll 44 adult smokers who smoke at least 10 cigarettes per day and are willing to try to reduce or stop smoking for 3 weeks. Participants will take daridorexant and monitor their sleep and smoking using a device and daily diaries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Legacy Research Institute
Portland, Oregon, 97232, United States
Conditions
Explore the condition pages connected to this study.